binding affinity News and Research

RSS
Model for investigating the effect of mutations on the binding affinity of the SARS-CoV-2 RBD-ACE2 complex

Model for investigating the effect of mutations on the binding affinity of the SARS-CoV-2 RBD-ACE2 complex

Sino Biological and Ainnocence Partner to Offer Next-Generation Antibody Development CRO Services

Sino Biological and Ainnocence Partner to Offer Next-Generation Antibody Development CRO Services

Study reveals differences in SARS-CoV-2 and SARS-CoV-1 spike protein conformational changes

Study reveals differences in SARS-CoV-2 and SARS-CoV-1 spike protein conformational changes

Molecular dynamic simulations unveil conformational dynamics of SARS-CoV-2 spike protein RBD and ACE2 receptor

Molecular dynamic simulations unveil conformational dynamics of SARS-CoV-2 spike protein RBD and ACE2 receptor

Angiotensin-converting enzyme 2 allosteric binders found to be effective against SARS-CoV-2

Angiotensin-converting enzyme 2 allosteric binders found to be effective against SARS-CoV-2

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

Acacetin shows potency against SARS-CoV-2 spike protein

Acacetin shows potency against SARS-CoV-2 spike protein

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

In silico screening of natural ACE2 inhibitors

In silico screening of natural ACE2 inhibitors

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

Mushroom-derived compounds have potential for use as COVID-19 therapeutic

Mushroom-derived compounds have potential for use as COVID-19 therapeutic

How will mutations change the SARS-CoV-2 spike protein in the future?

How will mutations change the SARS-CoV-2 spike protein in the future?

SARS-CoV-2 spike protein characteristics responsible for viral evolution in human hosts

SARS-CoV-2 spike protein characteristics responsible for viral evolution in human hosts

Omicron-based vaccine candidate generated to assess whether immunogenicity could be further improved

Omicron-based vaccine candidate generated to assess whether immunogenicity could be further improved

Identification of a rapid test for SARS-CoV-2 neutralization via antibodies and nanobodies

Identification of a rapid test for SARS-CoV-2 neutralization via antibodies and nanobodies

Study provides new insights into the communication of bacteria with their host

Study provides new insights into the communication of bacteria with their host

Impact of humoral responses in COVID-19

Impact of humoral responses in COVID-19

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.